查詢結果分析
相關文獻
- Postoperative Concurrent Chemotherapy and Radiotherapy for Resectable Locally Advanced Gastric Cancer Patients--A Preliminary Report
- 可切除性直腸癌術前輔助治療的療效評估
- 臺灣的動物輔助治療
- 下顎骨放射性骨壞死之高壓氧輔助治療
- Hyperbaric Oxygen Therapy for Diabetic Foot
- 慢性骨髓炎與高壓氧輔助治療
- 使用局部藥物釋出系統在牙周輔助治療中的角色
- Giant Vaginal Leiomyosarcoma: Successful Management with Trans-Arterial Embolization and Chemotherapy
- 低能量雷射在牙科應用
- 以高壓氧為輔助性療法治療顏面骨放射性骨壞死之臨床經驗
頁籤選單縮合
題名 | Postoperative Concurrent Chemotherapy and Radiotherapy for Resectable Locally Advanced Gastric Cancer Patients--A Preliminary Report=對局部廣泛性胃癌進行術後合併化療及放療之輔助治療初步結果報告 |
---|---|
作者 | 常慧如; 鄭鴻鈞; 劉美瑾; 簡哲民; 陳啟明; | 書刊名 | 放射治療與腫瘤學 |
卷期 | 4:3 1997.09[民86.09] |
頁次 | 頁195-201 |
分類號 | 416.36 |
關鍵詞 | 局部廣泛性胃癌; 輔助治療; Locally advanced gastric cancer; Adjuvant therapy; |
語文 | 英文(English) |
中文摘要 | 目的:於 1993 年 9 月至 1995 年 12 月間, 13 位胃癌高危險群病人於辜公亮 基金會孫逸仙醫院接受手術後合併化療及放療之輔助治療。本研究目的在評估於局部廣泛性 胃癌病人進行術後合併化療及放療輔助治療之可行性。 材料與方法:放射治療於手術後 4 至 6 週進行,於 4 至 5 週間投予胃部及上腹淋巴引流 區 3440 至 4320 cGy 放射治療。每位病人皆有電腦斷層治療計畫及特製鉛塊,化學治療乃 同時進行,處方為 5-FU 為主每月或每週連續式給予。 結果:四位病人發生 3 級嘔吐及噁心,其中一人於 3440 cGy 時提前結束治療, 全部病人 平均追�j 20 個月( 11 至 48 個月),沒有病人發生單獨性局部復發,僅有一位病人於殘 留胃局部復發,但同時合併腹腔復發,有三位病人發生遠端轉移。 結論:在局部廣泛性胃癌病人進行術後合併化療及放療輔助治療,其急性期副作用是可接受 的,短期之疾病控制及存活率與其他類似研究結果相同,合併化療及放療最恰當的處方與劑 量,仍須進一步研究。 |
英文摘要 | Purpose: To evaluate the feasibility of postoperative adjuvant concurrent chemotherapy and radiotherapy for locally advanced gastric cancer patients. Materials and Methods: From September 1993 to December 1995, 13 patients who had locally advanced gastric cancer were treated with postoperative concurrent chemotherapy and radiotherapy (CCRT) at the Koo Foundation Sun Yat-Sen Cancer Center. Radiotherapy was given in the range of 3440 cGy to 4320 cGy in 4 to 5 weeks to the gastric bed and upper abdominal nodal draining regions beginning 4 to 6 weeks after surgery. All patients had computerized tomography treatment planning and customized shaping blocks. 5-Fluorouracil based chemotherapy with either monthly or weekly continuous infusion were prescribed concomitantly. Results: Four patients developed grade 3 nausea and vomiting. One of them discontinued the CCRT earlier after the dose of 3440 cGy. At the median follow up interval of 20 months (ranged from 11 to 48 months), 10 patients were free of disease. Three patients developed recurrence. Conclusion: Our preliminary results suggest that the acute toxicity were moderate for patients with locally advanced gastric cancer who underwent postoperative CCRT using 5-FU based chemotherapy and radiotherapy up to 4000 cGy in standard fractionation. The short term disease control and survival are promising as compared with those reported by other institutions with adjuvant treatment in resected gastric patients. We suggest gastric cancer patients with T3,4 or N1,2 disease should be enrolled into clinical trial of adjuvant therapy postoperatively. The most appropriate radiation dosage and chemotherapy regimen needs further investigation. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。